| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.61▼ | 1.61▼ | 1.60▼ | 1.61▼ | 1.63▼ |
| MA10 | 1.61▼ | 1.62▼ | 1.61▼ | 1.61▼ | 1.77▼ |
| MA20 | 1.61▼ | 1.61▼ | 1.60▼ | 1.61▼ | 2.21▼ |
| MA50 | 1.64▼ | 1.61▼ | 1.60▼ | 1.80▼ | 3.29▼ |
| MA100 | 1.62▼ | 1.59▼ | 1.64▼ | 2.27▼ | 2.48▼ |
| MA200 | 1.61▼ | 1.73▼ | 1.83▼ | 2.95▼ | 1.84▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.002▼ | -0.002▼ | 0.015▲ | -0.017▼ |
| RSI | 43.878▼ | 44.984▼ | 46.133▼ | 39.787▼ | 32.245▼ |
| STOCH | 22.222 | 15.278▼ | 19.765▼ | 44.432 | 16.345▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -52.000 | -90.692▼ |
| CCI | -110.966▼ | -108.991▼ | -127.141▼ | -4.468 | -95.803 |
|
Tuesday, August 11, 2026 07:00 AM
IMNN-001 is the first frontline treatment candidate to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with ovarian cancer Enrollment in the ...
|
|
Tuesday, August 04, 2026 12:59 AM
IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage biotechnology company developing DNA-mediated immunotherapies, today announced that the Company will host a conference call at 11:00 a.m. EDT on Tuesday, ...
|
|
EXCLUSIVE: Imunon Outlines Accelerated Timeline, Strong Safety Data for Pivotal Ovarian Cancer Study
Thursday, July 30, 2026 05:30 AM
Clinical-stage biotechnology firm Imunon Inc. (NASDAQ:IMNN) on Thursday announced an update on its pivotal Phase 3 OVATION 3 trial evaluating IMNN-001 in newly diagnosed advanced ovarian cancer ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/08/26 | 1.59 | 1.59 | 1.59 | 1.59 | 14,375 |
| 12/08/26 | 1.63 | 1.64 | 1.59 | 1.61 | 27,082 |
| 11/08/26 | 1.61 | 1.67 | 1.5725 | 1.61 | 54,332 |
| 10/08/26 | 1.63 | 1.68 | 1.58 | 1.63 | 38,415 |
| 07/08/26 | 1.64 | 1.64 | 1.58 | 1.61 | 21,706 |
| 06/08/26 | 1.6769 | 1.6769 | 1.55 | 1.58 | 36,165 |
| 05/08/26 | 1.6072 | 1.65 | 1.55 | 1.59 | 44,696 |
| 04/08/26 | 1.57 | 1.71 | 1.57 | 1.67 | 98,506 |
| 03/08/26 | 1.5563 | 1.63 | 1.555 | 1.58 | 36,315 |
| 31/07/26 | 1.58 | 1.61 | 1.57 | 1.59 | 46,142 |
|
|
||||
|
|
||||
|
|